Professor Paul RuffProfessor Paul Ruff has been Chief Specialist, Professor and Head of the Division of Medical Oncology at the University of Witwatersrand Faculty of Health Sciences and Charlotte Maxeke Johannesburg Academic Hospital since 2002. He has been Principal Investigator of the SA Medical Research Council / University of Witwatersrand Common Epithelial Cancer Research Centre since 2015, and is co-Principal Investigator of NIH Grant 1R01CA192627 with Dr A Neugut of Columbia University School of Medicine, New York, USA.
Professor Ruff is a B2 rated scientist by the National Research Foundation of South Africa and has a Scopus H-index score of 30. Professor Ruff has been Chair of the South African Health Products Regulatory Authority Clinical Trials Committee since 2015, Chair of the Tertiary/Quaternary Essential Medicines List Committee and Vice-Chair of the Ministerial Advisory Committee on Cancer Control and Prevention and Member of National Essential Medicines List Committee since 2017.
Professor Ruff was appointed to the ASCO International Affairs Committee from 2013-16 and the ASCO International Clinical Trials Workshop Working Group from 2015-2018 and was part of the UICC Review Team of the WHO’s List of Essential Cancer Medicines (2015). Prof Ruff is a Member of South African Society of Medical Oncology Executive Committee, having been Chair from 2009-2013. Prof Ruff has authored or co-authored over 90 scientific papers, predominantly in the field of colorectal cancer, in various peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology and Lancet Oncology, as well as presenting over 200 papers and posters at local and international scientific meetings.